Back to curriculum
Domain

Critical Care Cardiology

Modules

Cardiogenic Shock Pathways

Team-based, hub-and-spoke, and mechanical support ladders.

The Cardiogenic Shock Spiral

↓ CardiacoutputCompensatoryvasoconstriction↑ Afterload,O2 demandWorseninghypoperfusionSystemicinflammationFurtherneurohormonal ↑

Cardiogenic shock begins with a primary fall in cardiac output from pump failure, which triggers compensatory sympathetic and renin-angiotensin-aldosterone activation. These responses raise systemic vascular resistance and heart rate to defend blood pressure, but the resulting rise in afterload further reduces stroke volume from the failing ventricle, and tachycardia increases myocardial oxygen demand. The consequent tissue hypoperfusion activates a systemic inflammatory response with cytokine release and, in some patients, inappropriate vasodilation resembling a mixed shock state. Left untreated, this creates a self-perpetuating spiral of falling cardiac output, rising afterload, and worsening end-organ hypoperfusion, which is why early mechanical or pharmacologic interruption of the cycle is central to management.

Team-Based Approach

Multi-disciplinary shock teams (cardiology, CT surgery, intensivist, interventional) improve outcomes. Rapid transfer to shock centers.

Escalation Ladder

Illustration of an intra-aortic balloon pump positioned in the aorta (Wikimedia Commons, CC BY-SA 4.0)Norepi + inotrope → IABP or Impella CP (temporary MCS) → Impella 5.5 or VA-ECMO → durable LVAD or transplant. Guided by SCAI stage, RV function, and reversibility.

RV Failure in Shock

Under-recognized. Echo (dilated RV, McConnell's, TAPSE), CVP:PCWP >0.86. Support: pulmonary vasodilators (inhaled NO/prostacyclin), inotropes, RV MCS (Protek Duo, Impella RP).

SCAI Shock Stages

StageExam / perfusionBiochemicalHemodynamicsAAt risk — normal exam, warm and well-perfusedNormal labsNormal hemodynamicsBBeginning — elevated JVP, warm, well-perfusedNormal lactateSBP preserved, mild tachycardiaCClassic — cool, clammy, altered mentation, oliguriaLactate ≥2, worsening renal functionHypotension needing intervention beyond fluidsDDeteriorating — like C but not responding to initial supportRising lactateRequires escalating pressor/device supportEExtremis — circulatory collapse, often peri-arrestSevere/refractory lactic acidosisRefractory to maximal support, pulselessness/CPRReassess stage frequently — trajectory, not the admission stage, should drive escalationThe SCAI staging system (A through E) captures the trajectory from at-risk to extremis and correlates with mortality, giving a common language for escalation decisions across specialties. Reassessing the stage frequently, rather than anchoring to the admission stage, is what actually drives timely escalation of support.
Clinical pearls
·
The most common mistake in cardiogenic shock is not escalating early enough — decision-making within 6 hours matters more than the specific device selected.
·
VA-ECMO increases LV afterload — combine with LV venting (Impella, IABP, or surgical) when LV distension develops.
·
Cardiac power output (MAP x cardiac output / 451) is one of the strongest single hemodynamic predictors of in-hospital mortality in cardiogenic shock.
·
Per the 2025 ACS guideline, routine IABP use in ACS-related cardiogenic shock is a Class III recommendation given no demonstrated mortality benefit.
·
Trending lactate clearance and mixed/central venous oxygen saturation, not a single value, is what guides escalation decisions along the shock pathway.
Related guidelines